New Chair of the Board: Paul Edwards MBE

Paul brings over 40 years of experience in life sciences, including senior leadership roles at Beecham Pharmaceuticals, Genzyme, and GeneMedix where he led the company’s dual listing on the London and Singapore Stock Exchanges.

Forge has grown rapidly since its founding two years ago. We’ve developed and deployed a powerful, novel genetic engineering platform to solve problems for leading pharmaceutical and biotech companies. With Paul’s experience in scaling biotech businesses, we’re entering an exciting new phase of growth and impact.

“I’m really excited to be joining Forge Genetics, a company based on cutting-edge science and led by a dynamic management team. I truly believe this is a company that can become a significant player in the genetic engineering arena.”

— Paul Edwards MBE

“Paul’s experience in building biotech companies and navigating the pharmaceutical landscape will be invaluable as Forge continues to grow and bring its technology to the world.”

— Craig Woods, CEO, Forge Genetics